Each year, ten million cataract surgeries are performed world-wide*. In the literature, the incidence of post-operative secondary cataract, varies anywhere between ten to fifty percent within three to five years.
It is clear the value of Nd:YAG laser treatment for secondary cataract remains undisputed; and with the redesign of Quantel Medical’s flagship Nd:YAG Laser, Lumibird Medical delivers CapsuloTM; the next generation technology, continuing to support this important growing market need.
Matthew Metcalfe, Anterior Segment Laser Product Manager at Lumibird Medical says this about the laser, “CAPSULO is built with exclusive high-quality optics delivering pristine clarity of view into the anterior and posterior segments of the eye. Advanced illumination with a variable-height light tower offers dual illumination angles of 16 and 7.5° for anterior and posterior laser applications".
The Capsulo™ Nd:YAG laser can be paired with the Quantel Medical Vitra 2® MultiSpot photocoagulating laser, also from Lumibird Medical, combining pan-retinal photocoagulation functionality through a single slit lamp.
Jean-Marc GENDRE, CEO Lumibird Medical explains, “Capsulo™, when combined with the Vitra 2® photocoagulator, offers an ideal all-in one laser platform, and we are extremely proud to provide this highly versatile solution into the hands of discerning ophthalmologists.”
Find more information about CAPSULO: https://www.quantel-medical.com/products/ophthalmology/laser/capsulo
*The world health report. Life in the 21st century: a vision for all. Geneva: World Health Organization, 1998:47